David S. Fryd
About
In The Last Decade
David S. Fryd
96 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 98
- Epidemiology 1.2k
- Transplantation 1.2k
- Surgery 1.1k
- Public Health, Environmental and Occupational Health 417
- Nephrology 414
Countries citing papers authored by David S. Fryd
This map shows the geographic impact of David S. Fryd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Fryd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Fryd more than expected).
Fields of papers citing papers by David S. Fryd
This network shows the impact of papers produced by David S. Fryd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Fryd. The network helps show where David S. Fryd may publish in the future.
Co-authorship network of co-authors of David S. Fryd
This figure shows the co-authorship network connecting the top 25 collaborators of David S. Fryd. A scholar is included among the top collaborators of David S. Fryd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Fryd. David S. Fryd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 44 | |
| 4 | 10 | |
| 5 | Adult kidney retransplantation: evolution of treatment and results over 25 years at the University of Minnesota. | 4 |
| 6 | 56 | |
| 7 | 433 | |
| 8 | 15 | |
| 9 | Living related kidneys continue to provide superior results over cadaveric kidneys in the cyclosporine era | 1 |
| 10 | 6 | |
| 11 | 62 | |
| 12 | 1 | |
| 13 | 14 | |
| 14 | 4 | |
| 15 | 55 | |
| 16 | 6 | |
| 17 | 14 | |
| 18 | 41 | |
| 19 | 30 | |
| 20 | Comparison of cyclosporine and azathioprine for immunosuppression in diabetic and nondiabetic renal allograft recipients | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.